Atrium Therapeutics, Inc.
corporate_fare Company Profile
Atrium Therapeutics, Inc. (NASDAQ:RNA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for RNA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Avidity Biosciences Files Proxy Materials for Novartis Merger and Spin-Off of Cardiology Assets
show_chartPrice Chart
Loading chart...
feed RNA - Filings & News (Page 2)
RNA
Jan 12, 2026, 4:30 PM EST
Price at Filing:
$72.35
Real-time Price:
$6.92
Change:
-$65.43 (-90%)
Market Cap:
$149.275M